GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $202,000 | -47.8% | 6,874 | -22.7% | 0.02% | -36.8% |
| Q2 2022 | $387,000 | -99.9% | 8,897 | -1.9% | 0.04% | +18.8% |
| Q1 2022 | $394,962,000 | -0.1% | 9,067 | +1.1% | 0.03% | 0.0% |
| Q4 2021 | $395,297,000 | +17.0% | 8,964 | +1.4% | 0.03% | +10.3% |
| Q3 2021 | $337,916,000 | +143084.7% | 8,844 | +49.5% | 0.03% | -3.3% |
| Q2 2021 | $236,000 | -20.8% | 5,915 | -29.1% | 0.03% | -6.2% |
| Q1 2021 | $298,000 | +14.2% | 8,339 | +17.4% | 0.03% | -3.0% |
| Q4 2020 | $261,000 | -31.0% | 7,103 | -29.4% | 0.03% | -35.3% |
| Q3 2020 | $378,000 | -7.1% | 10,064 | +0.8% | 0.05% | -22.7% |
| Q2 2020 | $407,000 | +17.3% | 9,987 | +8.9% | 0.07% | -9.6% |
| Q1 2020 | $347,000 | -19.5% | 9,171 | +0.1% | 0.07% | -1.4% |
| Q4 2019 | $431,000 | +93.3% | 9,160 | +71.7% | 0.07% | +23.3% |
| Q1 2019 | $223,000 | -43.0% | 5,334 | -47.8% | 0.06% | -37.5% |
| Q4 2018 | $391,000 | -40.4% | 10,223 | -37.4% | 0.10% | +3.2% |
| Q3 2018 | $656,000 | +152.3% | 16,333 | +153.3% | 0.09% | +17.7% |
| Q2 2018 | $260,000 | -8.1% | 6,448 | -10.9% | 0.08% | -10.2% |
| Q1 2018 | $283,000 | -8.4% | 7,240 | -16.9% | 0.09% | +14.3% |
| Q4 2017 | $309,000 | -19.7% | 8,717 | -8.0% | 0.08% | -38.9% |
| Q3 2017 | $385,000 | -4.7% | 9,475 | +1.2% | 0.13% | -14.3% |
| Q2 2017 | $404,000 | -4.3% | 9,360 | -6.5% | 0.15% | -10.9% |
| Q1 2017 | $422,000 | +15.6% | 10,011 | +5.6% | 0.16% | -8.8% |
| Q4 2016 | $365,000 | -4.5% | 9,484 | +7.2% | 0.18% | -4.7% |
| Q3 2016 | $382,000 | -0.3% | 8,848 | +0.1% | 0.19% | -9.1% |
| Q2 2016 | $383,000 | -35.7% | 8,841 | +3.2% | 0.21% | -45.7% |
| Q1 2016 | $596,000 | +91.6% | 8,569 | +11.2% | 0.38% | +77.4% |
| Q4 2015 | $311,000 | -4.0% | 7,704 | -0.9% | 0.22% | +4.8% |
| Q3 2015 | $324,000 | -99.9% | 7,772 | -43.7% | 0.21% | +13.7% |
| Q2 2015 | $287,712,000 | +82339.0% | 13,802 | +82.3% | 0.18% | -19.5% |
| Q1 2015 | $349,000 | +9.4% | 7,571 | +1.5% | 0.23% | +24.9% |
| Q4 2014 | $319,000 | – | 7,458 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |